(Q41382981)

30 September 2017

title

Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease (English)

1 reference

adaptive radiation therapy

30 September 2017

main subject

0 references

author name string

Chung CT

1

1 reference

30 September 2017

Bogart JA

2

1 reference

30 September 2017

Adams JF

3

1 reference

30 September 2017

Sagerman RH

4

1 reference

30 September 2017

Numann PJ

5

1 reference

30 September 2017

Tassiopoulos A

6

1 reference

30 September 2017

Duggan DB

7

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

International Journal of Radiation Oncology Biology Physics

30 September 2017

published in

1 reference

30 September 2017

volume

37

1 reference

30 September 2017

issue

2

1 reference

30 September 2017

page(s)

405-409

1 reference

Incidence of second cancers in patients treated for Hodgkin's disease

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Solid cancer risk after treatment of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Multiple primary cancer risk after therapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Second cancers after radiotherapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Breast cancer after treatment of Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Leukemia following Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Immunobiological consequences of splenectomy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Cancer risk after splenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Hodgkin's disease: subsequent primary cancers in relation to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Risk of second cancers after treatment for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Splenectomy in Hodgkin's disease and second leukaemias.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Subsequent development of acute non-lymphocytic leukemia in patients treated for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2896%2900498-1

7 January 2021

10.1016/S0360-3016(96)00498-1

Identifiers

DOI

1 reference

30 September 2017

1 reference